CANNABINOIDS & PLANT- BASED WELLNESS PRODUCTS

Human physical health and wellness continues to be a real and present challenge, in spite of the significant scientific advances in healthcare. We need to advance the methods to sustainably manufacture current medicines and discover next generation therapies that change the health trajectory and improve well-being for billions of people.

GO TO MARKET

→ OTC Cannabinoids markets, national and international distributors, and white-label brands


THERAPEUTIC AREAS

→ Pain, Inflammation, Anxiety, Sleep disorders, etc.

Market Size

$11B BY 2027

POTENTIAL GLOBAL MARKET

Compounds

CBDa

CBGa

TCHa

CBCa

Varin Series

Rare Cannabinoids Hold Tremendous Promise for Human Health and Wellness

Another key opportunity for our production process is the medical and recreational cannabis markets, and the many rare cannabinoids produced by the plant. While research around THC and CBD continues to grow, we are still yet to uncover the potential benefits of rarer phytocannabinoids (THCV, CBG, et.) that are produced in much smaller quantities in the cannabis plant. There are 160 different cannabinoids, and we have barely begun scratching the surface in cannabis as well as thousands of other plants that show promise as therapeutics, topical treatments and cosmetics.

Cannabis Plant

Developing Cannabinoid Products Efficiently, Rapidly, and Sustainably

CB Therapeutics has become a proven supplier for researchers and product developers to obtain and use some of the lesser-known cannabinoids rather than relying on crop-grown cannabis which takes a substantial amount of time, money and energy to produce and process.

Now, with the availability of fermentation produced, bio-identical molecules, this research into cannabinoids and other plant-produced molecules is beginning, to understand what cannabinoids and other molecules work best for PTSD, sleep disorders, eczema, epilepsy, and many, many other conditions and symptoms.